Navigation Links
JNCI news brief: Surgeon training found effective in breast cancer sentinel lymph node trial
Date:8/24/2009

Training methods for surgeons who perform breast cancer sentinel lymph node resection were found to be effective in almost 97% of surgeons assessed, according to a new study published online August 24 in the Journal of the National Cancer Institute.

The randomized National Surgical Adjuvant Breast and Bowel Project B-32 trial is evaluating whether sentinel lymph node resection can achieve the same outcomes as axillary lymph node resectionthe surgical procedure designed to maximize breast cancer survival, provide regional control, and determine cancer stagebut with fewer side effects.

In this study, David N. Krag, M.D., of the Department of Surgery, College of Medicine, University of Vermont in Burlington, Vt., and colleagues assessed the effectiveness of three training methods (core-trained, site trained, and expedited training (in the case of those with extensive prior experience with the technique)) for the sentinel node resection, as well as overall protocol compliance and their relationship to technical outcomes.

Out of the 261 surgeons approved to randomly assign patients to the B-32 trial (to receive sentinel lymph node resection), 224 trained surgeons had an overall success rate of 96.9%, with no statistically significant difference among the three training groups. Among all surgeons, a statistically significant positive association was observed between the average number of procedural errors and the false-negative rate.

"Subgroup analysis identified some variation in false-negative rates that were related to audited outcome performance measures, indicating the value of similar auditing measures on future trials," the authors write.


'/>"/>

Contact: Steve Graff
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
Source:Eurekalert

Page: 1

Related medicine news :

1. JNCI news brief: High serum insulin levels and risk of prostate cancer
2. JNCI news brief: Antibody linked to chemotherapy drug inhibits ovarian cancer in lab
3. JNCI news brief: Breast cancer hormone receptor status and risk of a second primary tumor
4. JNCI news brief: Hepatitis B virus mutations may predict risk of liver cancer
5. JNCI news brief: Improving the biomarker pipeline for early cancer detection
6. In brief: New prognostic indicator for patients with IPF
7. Florida Spine Surgeon Alfred Bonati, M.D. Announces Results of National Poll Showing America's Doctors Oppose a Government-Run Health Care Plan
8. Heidelberg cardiac surgeons implant worlds first new DeBakey Heart Assist Device
9. Statement from the American College of Surgeons Regarding Recent Comments from President Obama
10. The Obesity Society Position on Recent Criticism of Surgeon General Nominee Regina Benjamin
11. American Association of Oral and Maxillofacial Surgeons Says Only Trained Dental and Medical Practitioners Should Administer and Monitor Anesthesia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent ... health departments have been awarded five-year accreditation status through the Public Health ... being served by a PHAB-accredited health department now extend to more than ...
(Date:9/21/2017)... ... September 21, 2017 , ... Preora Diagnostics Inc. , ... tests, has received two prestigious recognitions that acknowledge the promise of its PWS ... Preora has been named a Top 100 Finalist for the 16th annual Chicago ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... offices serving communities in northern Alabama and Georgia, is embarking on an extended ... by utilizing modern early detection methods. , US Breast Cancer statistics show ...
(Date:9/20/2017)... ... September 20, 2017 , ... On ... Best Places to Work in the Research Triangle for 2017. , Winners were ... company had to meet a threshold in employee participation--a percentage that varies based ...
(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer True ... edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes Convention ... speakers — representing such thought-leading companies as JP Morgan Chase, GE Digital, ...
Breaking Medicine News(10 mins):
(Date:9/1/2017)... PALMER, Mass. , Sept. 1, 2017 ... Complete HealthCare Solutions, Inc , highlights opportunities for growth ... Street Journal report that Marlin Equity is seeking a ... is an annual award-winning 22-year-old healthcare solutions Value Added ... market.  "As the ...
(Date:8/29/2017)... -- ivWatch, LLC, the leading provider of continuous monitoring devices for ... awarded an Innovative Technology contract from Vizient, Inc., the largest member-driven ... ... early detection of peripheral IV infiltration and extravasation events ... The Innovative Technology contract was awarded to ivWatch based ...
(Date:8/25/2017)... ), an Irish medtech company, today announced that it has commenced working ... Bassetlaw, England . The collaboration sees the company,s ... national NHS Test Bed programme exploring new models of care. ... Innovation Zed ... accessory for disposable insulin pen users, automatically collects and records pen usage ...
Breaking Medicine Technology: